Tag Archives: Type

AZ's Farxiga nabbed its Type 1 nod in EU. But after Zynquista's rebuff, how will it fare at FDA?

AstraZeneca’s Farxiga just won European approval in Type 1 diabetes, but its prospects in the U.S. are less certain. The FDA’s rejection of Sanofi and Lexicon Pharmaceuticals’ would-be rival Zynquista may serve as an ill omen in Type 1 for the entire SGLT class. Both Farxiga (marketed as Forxiga in Europe) and Zynquista previously secured… Read More »

FDA stiff-arms Sanofi and Lexicon's Type 1 diabetes hopeful Zynquista

The FDA stiff-armed Sanofi and Lexicon’s diabetes drug Zynquista on Friday, darkening the companies’ hopes of launching the drug for Type 1 diabetes this year. It’s not a complete surprise, because an FDA advisory panel was split right down the middle on whether to approve the SGLT1/2 drug. But the FDA could have chosen the positive side… Read More »